<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707014</url>
  </required_header>
  <id_info>
    <org_study_id>CHT00028</org_study_id>
    <nct_id>NCT04707014</nct_id>
  </id_info>
  <brief_title>Hypnoanalgesia for Dermatological Surgery in Children</brief_title>
  <official_title>Effectiveness of Hypnoanalgesia for Dermatological Surgery in Children: Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complejo Hospitalario de Toledo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complejo Hospitalario de Toledo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial will evaluate the effect of hypnosedation on the need of&#xD;
      sedation and analgesia in a pediatric population undergoing dermatological surgery, both&#xD;
      during the procedure, and 24 hours after surgery. In addition, a secondary objetive is to&#xD;
      evaluate the effect by specific age groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this clinical trial, pediatric patients scheduled for removal of benign skin lesions in a&#xD;
      single center willbe randomised to receive hypnosis (intervention group) or&#xD;
      attention-distracting techniques (control group). Endpoints will be the sedative dose&#xD;
      (propofol) during surgery, and the need for analgesia (paracetamol and others) immediately&#xD;
      after surgery (recovery) and after 24 hours. Randomization will be systematic in blocks&#xD;
      depending on the day the surgery is programmed. Hypnosis will be delivered by an experienced&#xD;
      anesthesist trained in the technique. Patients and families will be informed of the special&#xD;
      treatment during surgery, but will be unaware of whether the patients are experiencing&#xD;
      distraction or hypnosis techniques. Distraction is already a useful technique, and it is&#xD;
      expected that patients will be satisfied with the procedure; however, the hypothesis to be&#xD;
      tested is that hypnosis reduces the need for sedation and analgesia compared to distraction&#xD;
      techniques, as well as improves satisfaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">April 30, 2018</completion_date>
  <primary_completion_date type="Actual">April 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients are randomly distributed to one of the following groups:&#xD;
Intervention group: Technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.&#xD;
Control group: High-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Different investigators are assigned to each phase of the study, with one designated as responsible for recruitment (MQD), another for intervention and control (JMPP), and another for subsequent evaluation in the post-anaesthesia recovery unit (URPA) and at 24 hours (responsible nursing staff).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total dose of propofol in mg/kg</measure>
    <time_frame>During surgery (Intra-operative)</time_frame>
    <description>Measured in mg/kg weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total dose of propofol in mg</measure>
    <time_frame>During surgery (Intra-operative)</time_frame>
    <description>Measured in total mg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Additional need for opioids during surgery</measure>
    <time_frame>During surgery (Intra-operative)</time_frame>
    <description>Yes/no</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity in older children post-operative</measure>
    <time_frame>Immediately post-operative while on recovery unit</time_frame>
    <description>0-10 visual analogue scale (VAS) administered by a blinded nurse, with higher values indicating higher levels of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity in younger children post-operative</measure>
    <time_frame>Immediately post-operative while on recovery unit</time_frame>
    <description>0-10 Faces Pain Scale - Revised (FPS-r) administered by a blinded nurse, with higher values indicating higher levels of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity in older children after 24 hours</measure>
    <time_frame>24 hours after discharge</time_frame>
    <description>0-10 visual analogue scale (VAS) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity in younger children after 24 hours</measure>
    <time_frame>24 hours after discharge</time_frame>
    <description>0-10 Faces Pain Scale - Revised (FPS-r) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic need</measure>
    <time_frame>24 hours after discharge</time_frame>
    <description>Recorded by a blinded nurse at reanimation unit as yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic needs</measure>
    <time_frame>24 hours after discharge</time_frame>
    <description>Recorded by a blinded nurse by telephone call as yes/no</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Degree of satisfaction with the procedure</measure>
    <time_frame>24 hours after discharge</time_frame>
    <description>Validated survey with score 1-10 administered at the time of discharge to children and their guardians.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Attention-Distraction techniques</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A high-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIPNOSIS GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to the child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hypnosis</intervention_name>
    <description>Rapid conversational hypnosis</description>
    <arm_group_label>HIPNOSIS GROUP</arm_group_label>
    <other_name>Hypnoanalgesia</other_name>
    <other_name>Hypnosedation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention-distracting techniques</intervention_name>
    <description>i-pad with movies, games and music</description>
    <arm_group_label>Attention-Distraction techniques</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. A class I or II of anaesthetic risk according to the American Society of&#xD;
             Anesthesiologists,&#xD;
&#xD;
          2. to be in a percentile between P3 and P97 in weight and height,&#xD;
&#xD;
          3. without known drug allergies, and&#xD;
&#xD;
          4. having fasted 6 hours for solids and 2 hours for water.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Children with diagnosed mental retardation or attention deficit,&#xD;
&#xD;
          2. behavioural disorders,&#xD;
&#xD;
          3. previous treatment with hypnosis,&#xD;
&#xD;
          4. history of neurological pathology or psychomotor retardation,&#xD;
&#xD;
          5. previous pain-related pathology,&#xD;
&#xD;
          6. obstructive sleep apnoea syndrome (OSAS)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juana Maria PELAEZ PEREZ, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Toledo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Complejo Hospitalario Toledo</name>
      <address>
        <city>Toledo</city>
        <zip>45002</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Friedrichsdorf SJ, Kohen DP. Integration of hypnosis into pediatric palliative care. Ann Palliat Med. 2018 Jan;7(1):136-150. doi: 10.21037/apm.2017.05.02. Epub 2017 Jun 27. Review.</citation>
    <PMID>28866891</PMID>
  </reference>
  <reference>
    <citation>Kendrick C, Sliwinski J, Yu Y, Johnson A, Fisher W, Kekecs Z, Elkins G. Hypnosis for Acute Procedural Pain: A Critical Review. Int J Clin Exp Hypn. 2016;64(1):75-115. doi: 10.1080/00207144.2015.1099405. Review.</citation>
    <PMID>26599994</PMID>
  </reference>
  <reference>
    <citation>Brown ML, Rojas E, Gouda S. A Mind-Body Approach to Pediatric Pain Management. Children (Basel). 2017 Jun 20;4(6). pii: E50. doi: 10.3390/children4060050. Review.</citation>
    <PMID>28632194</PMID>
  </reference>
  <reference>
    <citation>Friedrichsdorf SJ, Goubert L. Pediatric pain treatment and prevention for hospitalized children. Pain Rep. 2019 Dec 19;5(1):e804. doi: 10.1097/PR9.0000000000000804. eCollection 2020 Jan-Feb.</citation>
    <PMID>32072099</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Complejo Hospitalario de Toledo</investigator_affiliation>
    <investigator_full_name>JUANA MARIA PELAEZ PEREZ</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>anxiety</keyword>
  <keyword>pain</keyword>
  <keyword>paediatric surgery</keyword>
  <keyword>dermatology</keyword>
  <keyword>Hypnosis</keyword>
  <keyword>Nervous System Diseases Central</keyword>
  <keyword>Hypnotics and Sedatives</keyword>
  <keyword>Nervous System Depressants</keyword>
  <keyword>Physiological Effects of Drugs</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Any document upon reasonable request to the PI.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Up to 1 year after publication</ipd_time_frame>
    <ipd_access_criteria>Justified interest in data. By e-mail to PI</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol: HYPNOANALGESIA IN PEDIATRIC DERMATOLOGICAL SURGERY</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04707014/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: STATISTICAL ANALYSIS</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04707014/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04707014/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

